Common Contracts

Supply Agreement

Supply Agreement • February 25th, 2021 • Mannkind Corp • Pharmaceutical preparations • Delaware

• Contract Type
  Supply Agreement
• Filed
  February 25th, 2021
• Company
  Mannkind Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Supply Agreement (the “Agreement”) is made as of the 31st day of July, 2014 (the “Effective Date”) by and between MannKind Corporation, a Delaware corporation (“MannKind”), with its principal office and place of business at 28903 North Avenue Paine, Valencia, CA 91355, U.S.A., and Amphastar France Pharmaceuticals S.A.S., a French corporation (“AFP”), with its principal office and place of business at Usine Saint-Charles, 60590 Eragny-Sur-Epte, France (each of MannKind and AFP, a “Party” and together, the “Parties”).

EX-10.3 5 d783199dex103.htm EX-10.3 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 28903 North Avenue Paine, Valencia, California 91355 USA 61 South Paramus Road, Paramus, New...

Supply Agreement • May 5th, 2020 • Delaware

• Contract Type
  Supply Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Delaware

THIS SUPPLY AGREEMENT (the “Agreement”) is made as of the 31st day of July, 2014 (the “Effective Date”) by and between MannKind Corporation, a Delaware corporation (“MannKind”), with its principal office and place of business at 28903 North Avenue Paine, Valencia, CA 91355, U.S.A., and Amphastar France Pharmaceuticals S.A.S., a French corporation (“AFP”), with its principal office and place of business at Usine Saint-Charles, 60590 Eragny-Sur-Epte, France (each of MannKind and AFP, a “Party” and together, the “Parties”).

SUPPLY AGREEMENT

Supply Agreement • November 10th, 2014 • Mannkind Corp • Pharmaceutical preparations • Delaware

• Contract Type
  Supply Agreement
• Filed
  November 10th, 2014
• Company
  Mannkind Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS SUPPLY AGREEMENT (the “Agreement”) is made as of the 31st day of July, 2014 (the “Effective Date”) by and between MannKind Corporation, a Delaware corporation (“MannKind”), with its principal office and place of business at 28903 North Avenue Paine, Valencia, CA 91355, U.S.A., and Amphastar France Pharmaceuticals S.A.S., a French corporation (“AFP”), with its principal office and place of business at Usine Saint-Charles, 60590 Eragny-Sur-Epte, France (each of MannKind and AFP, a “Party” and together, the “Parties”).